SC
VRTX icon

Sapient Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Sapient Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.35M Sell
17,891
-120
-0.7% -$61.4K 0.13% 84
2026
Q2 		$8.95M Sell
18,011
-981
-5% -$435K 0.12% 89
2026
Q1 		$8.48M Sell
18,992
-15,332
-45% -$7.15M 0.13% 94
2025
Q4 		$15.6M Buy
34,324
+13
+0% +$5.6K 0.22% 71
2025
Q3 		$13.6M Sell
34,311
-1,999
-6% -$835K 0.21% 73
2025
Q2 		$16.2M Buy
36,310
+314
+0.9% +$145K 0.29% 64
2025
Q1 		$17.5M Buy
35,996
+200
+0.6% +$93.2K 0.34% 60
2024
Q4 		$14.4M Buy
35,796
+498
+1% +$231K 0.28% 67
2024
Q3 		$16.4M Buy
35,298
+43
+0.1% +$20.7K 0.33% 59
2024
Q2 		$16.5M Sell
35,255
-20
-0.1% -$8.68K 0.34% 56
2024
Q1 		$14.7M Buy
35,275
+789
+2% +$334K 0.33% 64
2023
Q4 		$14M Buy
+34,486
New +$12.7M 0.36% 61

Other funds holding VRTX

MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GGS
Galvin Gaustad & Stein Scottsdale, Arizona $1.33B AUM 13.15% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
LJHT
Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return
CFG
Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Sapient Capital's VRTX Position: Q3 2026 in Review

Sapient Capital reduced its Vertex Pharmaceuticals (VRTX) stake by 0.67% in Q3 2026, selling an estimated $61.4K and leaving 17,891 shares worth $9.35M. The position accounts for 0.13% of the portfolio, ranked #84.

Sapient Capital first reported a position in VRTX in Q4 2023 and has held it in 12 quarters since. The position peaked at $17.5M in Q1 2025. 66 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Sapient Capital held 17,891 shares of Vertex Pharmaceuticals worth $9.35M as of Q3 2026.
  • Sapient Capital sold 120 Vertex Pharmaceuticals shares in Q3 2026, an estimated $61.4K.
  • Vertex Pharmaceuticals made up 0.13% of Sapient Capital's portfolio in Q3 2026, its #84 holding.
  • Sapient Capital first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • Sapient Capital's Vertex Pharmaceuticals position peaked at $17.5M in Q1 2025.
  • 66 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Sapient Capital's 13F filing for Q3 2026, filed 8 Oct 2026.